Jane Street Group, LLC Pacira Bio Sciences, Inc. Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$60.03 - $76.49 $2.24 Million - $2.85 Million	37,300 Added 310.83%	49,300 $3.76 Million
Q4 2021 Feb 15, 2022	BUY	$47.97 - $62.21 $292,617 - $379,481	6,100 Added 103.39%	12,000 $722,000
Q3 2021 Nov 16, 2021	SELL	$54.64 - $61.3 $426,192 - $478,140	-7,800 Reduced 56.93%	5,900 $330,000
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $479,358 - $566,919	8,100 Added 144.64%	13,700 $831,000
Q4 2020 Feb 17, 2021	SELL	$50.47 - $66.26 $121,128 - $159,024	-2,400 Reduced 30.0%	5,600 $335,000
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $299,544 - $377,916	-8,400 Reduced 51.22%	8,000 $305,000
Q3 2018 Nov 14, 2018	SELL	$32.85 - $52.0 $16,425 - $26,000	-500 Reduced 2.96%	16,400 $806,000
Q2 2018 Aug 15, 2018	BUY	$27.5 - $39.8 $464,750 - $672,620	16,900 New	16,900 $542,000

301

51.5M

378K

1.53M

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $666M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.